Manufacturers Life Insurance Company, The Cassava Sciences Inc Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Cassava Sciences Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 15,242 shares of SAVA stock, worth $38,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,242
Previous 22,700 32.85%
Holding current value
$38,105
Previous $280,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$9.57 - $35.08 $71,373 - $261,626
-7,458 Reduced 32.85%
15,242 $448,000
Q2 2024

Aug 14, 2024
BUY
$12.35 - $26.11 $29,355 - $62,063
2,377 Added 11.7%
22,700 $280,000
Q1 2024

May 14, 2024
BUY
$18.44 - $26.41 $93,804 - $134,347
5,087 Added 33.39%
20,323 $412,000
Q4 2023

Feb 13, 2024
SELL
$12.64 - $30.11 $4,499 - $10,719
-356 Reduced 2.28%
15,236 $342,000
Q3 2023

Nov 15, 2023
SELL
$16.64 - $25.32 $10,167 - $15,470
-611 Reduced 3.77%
15,592 $259,000
Q2 2023

Aug 11, 2023
BUY
$21.59 - $27.88 $30,852 - $39,840
1,429 Added 9.67%
16,203 $397,000
Q1 2023

May 15, 2023
BUY
$23.46 - $36.44 $15,366 - $23,868
655 Added 4.43%
15,429 $372,000
Q4 2022

Aug 11, 2023
SELL
$27.82 - $44.16 $4,729 - $7,507
-170 Reduced 1.14%
14,774 $436,000
Q4 2022

Feb 13, 2023
SELL
$27.82 - $44.16 $4,729 - $7,507
-170 Reduced 1.14%
14,774 $436,000
Q3 2022

Aug 11, 2023
SELL
$16.33 - $51.06 $10,402 - $32,525
-637 Reduced 4.09%
14,944 $624,000
Q3 2022

Nov 03, 2022
SELL
$16.33 - $51.06 $10,402 - $32,525
-637 Reduced 4.09%
14,944 $625,000
Q2 2022

Aug 11, 2023
SELL
$17.22 - $38.47 $2,049 - $4,577
-119 Reduced 0.76%
15,581 $438,000
Q2 2022

Aug 15, 2022
SELL
$17.22 - $38.47 $2,049 - $4,577
-119 Reduced 0.76%
15,581 $438,000
Q1 2022

Aug 11, 2023
BUY
$32.6 - $53.05 $8,834 - $14,376
271 Added 1.76%
15,700 $583,000
Q1 2022

May 20, 2022
SELL
$32.6 - $53.05 $119,218 - $194,003
-3,657 Reduced 18.89%
15,700 $583,000
Q4 2021

Feb 16, 2022
SELL
$36.77 - $90.91 $12,943 - $32,000
-352 Reduced 1.79%
19,357 $846,000
Q3 2021

Nov 12, 2021
SELL
$41.79 - $135.3 $67,992 - $220,133
-1,627 Reduced 7.63%
19,709 $1.22 Million
Q2 2021

Aug 12, 2021
BUY
$32.15 - $89.72 $117,797 - $328,734
3,664 Added 20.73%
21,336 $1.82 Million
Q1 2021

May 03, 2021
SELL
$7.09 - $87.95 $19,121 - $237,201
-2,697 Reduced 13.24%
17,672 $794,000
Q4 2020

Feb 12, 2021
BUY
$6.79 - $12.25 $48,256 - $87,060
7,107 Added 53.59%
20,369 $139,000
Q3 2020

Nov 09, 2020
BUY
$2.86 - $11.51 $37,929 - $152,645
13,262 New
13,262 $153,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $100M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email